Previous close | 349.50 |
Open | 349.60 |
Bid | 346.69 x 1200 |
Ask | 346.20 x 800 |
Day's range | 345.89 - 350.94 |
52-week range | 334.54 - 541.21 |
Volume | |
Avg. volume | 1,988,380 |
Market cap | 41.797B |
Beta (5Y monthly) | 0.45 |
PE ratio (TTM) | 17.34 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 3.54 (1.01%) |
Ex-dividend date | 27 Mar 2024 |
1y target est | N/A |
Based on the average brokerage recommendation (ABR), Humana (HUM) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Humana Inc (NYSE:HUM) recently announced a dividend of $0.89 per share, payable on 2024-04-26, with the ex-dividend date set for 2024-03-27. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates. Using the data from GuruFocus, let's look into Humana Inc's dividend performance and assess its sustainability.
Hospitals and insurance giants are clashing over Medicare Advantage plans as both sides try to protect their profits. Many seniors are caught in the crosshairs.